These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 18192073

  • 1. The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.
    Fan J, Wang L, Jiang GN, He WX, Ding JA.
    Lung Cancer; 2008 Jul; 61(1):91-6. PubMed ID: 18192073
    [Abstract] [Full Text] [Related]

  • 2. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E, Visca P, Novelli F, Casini B, Diodoro MG, Perrone-Donnorso R, Botti C, Sperduti I, Facciolo F, Milella M, Cecere FL, Cognetti F, Mottolese M.
    Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
    [Abstract] [Full Text] [Related]

  • 3. Survivin gene expression in early-stage non-small cell lung cancer.
    Falleni M, Pellegrini C, Marchetti A, Oprandi B, Buttitta F, Barassi F, Santambrogio L, Coggi G, Bosari S.
    J Pathol; 2003 Aug; 200(5):620-6. PubMed ID: 12898598
    [Abstract] [Full Text] [Related]

  • 4. Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery.
    Dai CH, Li J, Shi SB, Yu LC, Ge LP, Chen P.
    Jpn J Clin Oncol; 2010 Apr; 40(4):327-35. PubMed ID: 20056675
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P, Li J, Ge LP, Dai CH, Li XQ.
    Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
    [Abstract] [Full Text] [Related]

  • 6. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S, Unsal E, Demirag F, Köksal D, Yilmaz A.
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [Abstract] [Full Text] [Related]

  • 7. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL, Liu D, Nakano J, Yokomise H, Ueno M, Kadota K, Wada H.
    Clin Cancer Res; 2007 Dec 01; 13(23):6938-46. PubMed ID: 18056168
    [Abstract] [Full Text] [Related]

  • 8. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.
    Shinohara ET, Gonzalez A, Massion PP, Chen H, Li M, Freyer AS, Olson SJ, Andersen JJ, Shyr Y, Carbone DP, Johnson DH, Hallahan DE, Lu B.
    Cancer; 2005 Apr 15; 103(8):1685-92. PubMed ID: 15742356
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 15; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 10. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
    Warnecke-Eberz U, Baldus SE, Bollschweiler E, Hoelscher AH, Metzger R.
    Anticancer Res; 2008 Oct 15; 28(3A):1525-9. PubMed ID: 18630507
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
    Timotheadou E, Skarlos DV, Samantas E, Papadopoulos S, Murray S, Skrickova J, Christodoulou C, Papakostantinou C, Pectasides D, Papakostas P, Kaplanova J, Vrettou E, Karina M, Kosmidis P, Fountzilas G.
    Anticancer Res; 2007 Oct 15; 27(6C):4481-9. PubMed ID: 18214064
    [Abstract] [Full Text] [Related]

  • 12. Telomerase activity in transthoracic fine-needle biopsy aspirates from non-small cell lung cancer as prognostic factor of patients' survival.
    Targowski T, Jahnz-Rózyk K, Szkoda T, Płusa T, From S.
    Lung Cancer; 2008 Jul 15; 61(1):97-103. PubMed ID: 18063440
    [Abstract] [Full Text] [Related]

  • 13. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 15; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 14. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.
    Cancer; 2009 Apr 01; 115(7):1507-17. PubMed ID: 19170237
    [Abstract] [Full Text] [Related]

  • 15. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer.
    Jung CK, Jung JH, Park GS, Lee A, Kang CS, Lee KY.
    Pathol Int; 2006 Sep 01; 56(9):503-9. PubMed ID: 16930330
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W.
    Hum Pathol; 2008 Jan 01; 39(1):126-36. PubMed ID: 17949785
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
    Derin D, Soydinç HO, Guney N, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E.
    Lung Cancer; 2008 Feb 01; 59(2):240-5. PubMed ID: 17875341
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer.
    Yie SM, Lou B, Ye SR, He X, Cao M, Xie K, Ye NY, Lin R, Wu SM, Xiao HB, Gao E.
    Lung Cancer; 2009 Feb 01; 63(2):284-90. PubMed ID: 18606477
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
    Soltermann A, Tischler V, Arbogast S, Braun J, Probst-Hensch N, Weder W, Moch H, Kristiansen G.
    Clin Cancer Res; 2008 Nov 15; 14(22):7430-7. PubMed ID: 19010860
    [Abstract] [Full Text] [Related]

  • 20. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 15; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.